<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Iran J Public Health</journal-id><journal-id journal-id-type="iso-abbrev">Iran. J. Public Health</journal-id><journal-id journal-id-type="publisher-id">IJPH</journal-id><journal-id journal-id-type="pmc">IJPH</journal-id><journal-title-group><journal-title>Iranian Journal of Public Health</journal-title></journal-title-group><issn pub-type="ppub">2251-6085</issn><issn pub-type="epub">2251-6093</issn><publisher><publisher-name>Tehran University of Medical Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27252912</article-id><article-id pub-id-type="pmc">4888170</article-id><article-id pub-id-type="publisher-id">ijph-45-435</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Predictive Role of Serum Tumor Markers in Diagnosis of Pulmonary Tuberculosis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>MA</surname><given-names>Jingjing</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>XIA</surname><given-names>Dan</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>HU</surname><given-names>Jing</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>FU</surname><given-names>Rui</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>XU</surname><given-names>Lijun</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>ZHANG</surname><given-names>Ying</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>ZHANG</surname><given-names>Mengying</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>LI</surname><given-names>Benhe</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>YANG</surname><given-names>Jianghua</given-names></name><xref ref-type="aff" rid="AFF2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>WEN</surname><given-names>Yufeng</given-names></name><xref ref-type="aff" rid="AFF1"><sup>1</sup></xref><xref ref-type="corresp" rid="C1"><sup>*</sup></xref></contrib><aff id="AFF1"><label>1</label>Dept. of Preventive Medicine, School of Public Health, Wannan Medical College, Wuhu City, China</aff><aff id="AFF2"><label>2</label>Dept. of Infectious Diseases, Yijishan Hospital, Wuhu City, China</aff></contrib-group><author-notes><corresp id="C1"><label>*</label><bold>Corresponding Author:</bold> Email:<email>wenwent2008@163.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>4</month><year>2016</year></pub-date><volume>45</volume><issue>4</issue><fpage>435</fpage><lpage>440</lpage><history><date date-type="received"><day>25</day><month>10</month><year>2015</year></date><date date-type="accepted"><day>16</day><month>2</month><year>2016</year></date></history><permissions><copyright-statement>Copyright&#x000a9; Iranian Public Health Association &#x00026; Tehran University of Medical Sciences</copyright-statement><copyright-year>2016</copyright-year><license><license-p>This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.</license-p></license></permissions><abstract><sec><title>Background:</title><p>The diagnosis of pulmonary tuberculosis (PTB) is complicated and time-consuming currently. There was association of PTB with serum tumor markers. In this study we aimed to evaluate the predictive role of serum CA125, CA199 and CEA as diagnostic tools for PTB.</p></sec><sec><title>Methods:</title><p>This study was designed as a case-control study with 565 subjects who visited the Yijishan Hospital from Jun to Dec in 2014.This case-control study matched as for age and sex with 113 cases and 452 controls. Serum CA125, CA199 and CEA levels were detected by electrochemiluminescence instrument. The area under the curve (AUC) of the receiver operating characteristic (ROC) curve was performed to evaluate the diagnostic value on PTB.</p></sec><sec><title>Results:</title><p>Serum levels of CA125, CA199 and CEA in PTB patients were significantly higher than those in control group (<italic>P</italic>&#x0003c;0.001). There was no significantly different of three tumor markers between initial treatment group and retreatment group. The logistic regression analysis showed that CA125 was an impact factor to PTB. The ROC analysis revealed that AUC of CA125 was 0.966 (95%CI: 0.951&#x02013;0.981), the sensitivity, specificity in serum and cut-off were 95.6%, 85.0% and 10.30 U/ml, respectively.</p></sec><sec><title>Conclusion:</title><p>The serum CA125 has potential good diagnostic performance for PTB.</p></sec></abstract><kwd-group><kwd>CA125</kwd><kwd>CA199</kwd><kwd>CEA</kwd><kwd>Pulmonary tuberculosis</kwd><kwd>Receiver-operating</kwd><kwd>Characteristic curve</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Tuberculosis is a leading cause of death, especially in low and middle income countries (
<xref rid="B1" ref-type="bibr">1</xref>
). China is one of the 22 high TB burden countries. The latest estimates included in the global TB report of 2014 that there were 9.0 million new TB cases in 2013 and 1.5 million TB deaths, among them China accounted for 11% new tuberculosis (
<xref rid="B2" ref-type="bibr">2</xref>
). Nevertheless, most deaths from TB are preventable by early diagnosis and treatment. Totally 37 million lives were saved between 2000 and 2013 through effective diagnosis and treatment (
<xref rid="B2" ref-type="bibr">2</xref>
). However recent studies showed extensive delay in TB diagnosis and treatment were severe (
<xref rid="B3" ref-type="bibr">3</xref>
). Hence, the crucial point to eradicate the disease is improving the diagnosis of tuberculosis.</p><p>In high prevalence of TB areas, the sputum smear microscopy test, with a sensitivity of 50%&#x02013;70%, is available and affordable (
<xref rid="B4" ref-type="bibr">4</xref>
). Although smear-negative cases are less infectious than smear-positive cases, at least 17% of TB cases are affected by smear-negative cases (
<xref rid="B5" ref-type="bibr">5</xref>
). The <italic>Mycobacterium</italic> culture is the golden standard for TB diagnosis, but the detection results cost a long time and have a low positive rate, the sensitivity of 43%&#x02013;83% (
<xref rid="B6" ref-type="bibr">6</xref>
). PCR test has found an increasingly wide utilization in TB diagnosis, but in developing areas its utilization remains limited because of the high cost of detection and the deficiency of special equipment and professional staffs (
<xref rid="B7" ref-type="bibr">7</xref>
, 
<xref rid="B8" ref-type="bibr">8</xref>
). Therefore, the cheap, accurate and rapid diagnostic tests for TB are much-needed (
<xref rid="B9" ref-type="bibr">9</xref>
).</p><p>In recent years, serum tumor markers were an effective and non-invasive diagnostic tool (
<xref rid="B10" ref-type="bibr">10</xref>
), and became a common clinical method for screening tumor (
<xref rid="B11" ref-type="bibr">11</xref>
). Interestingly, a study in 1995 reported that CA125 was increased in PTB (
<xref rid="B12" ref-type="bibr">12</xref>
), since then several studies reported that the serum levels of CA125, CA199, CEA in PTB were higher than those in normal population (
<xref rid="B13" ref-type="bibr">13</xref>
&#x02013;
<xref rid="B16" ref-type="bibr">16</xref>
). The results provided a clue that tumor markers had potential clinical value for the diagnosis of PTB possibly. However, the study on the predictive power of tumor markers and which tumor marker has higher sensitivity and specificity in diagnosis of PTB are uncleared.</p><p>In this study, we aimed to evaluate the sensitivity, specificity and cut-off of serum tumor markers to PTB diagnosis by ROC, and expected to evaluate the correlations between serum tumor markers and clinically relevant parameters of PTB.</p></sec><sec sec-type="materials|methods"><title>Materials and Methods</title><sec sec-type="methods|subjects"><title>Study subjects</title><p>This study was designed as a case-control study with 565 subjects who visited the Yijishan Hospital from Jun to Dec in 2014. Case group was selected from subjects with PTB diagnosed by physicians according to reference (
<xref rid="B17" ref-type="bibr">17</xref>
). Cases were excluded if there was a change in diagnosis during the treatment period, and the smokers were not enrolled in this study. Control group was selected from individuals who underwent physical examination in Center of Health Examination of Yijishan Hospital during the same period. If the subjects with systemic infections, history of pulmonary tuberculosis, closely contact with PTB patients, tumor, neoplastic diseases and gynecological disorders were excluded from control group. We also excluded the subjects who were in inflammatory conditions (confirmed by standard diagnostic criteria) with clinical features that could overlap the TB. For example, subjects with differential diagnosis of PTB, and other severe respiratory infections representing patients who had non-tuberculous destructive pulmonary pathology.</p><p>The case group was matched age and sex with control group. The distribution of PTB cases and controls was not intended to reflect a particular population or epidemiological setting, but to encompass a broad range of symptomatically overlapping clinical presentations. The information including demographic characteristics was extracted from the electronic medical record. The protocol of this study was approved by Medical Ethics Committee of Wannan Medical College, all participants had been informed about the study and gave their consent.</p></sec><sec><title>Serum tumor marker detection</title><p>All participants were characterized by sputum smear microscopy and culture including subsequent antigen or molecular confirmation of <italic>M. Tuberculosis</italic>. Serum samples were collected within 2 days of the first presentation and before initiation of treatment for PTB patients.</p><p>Three milliliter venous blood was collected from the patients fasted for 12 h and then centrifuged and stored at &#x02212;70 &#x000b0;C until assayed. Serum CEA, CA125 and CA199 were detected by Roche electrochemiluminescence instrument at Department of Nuclear Medicine of Yijishan Hospital. All detection reagents were the corresponding bundled reagents, and its operation was in strict accordance with the manual. The normal reference values were as follows: CEA&#x02264;5ng/ml, CAl25&#x02264;35 U/ml, and CAl99&#x02264; 37 U/ml.</p></sec><sec sec-type="methods"><title>Statistical analysis</title><p>Before analysis, means (SD) or median (25th percentile, 75th percentile) was calculated for continuous variables and proportions for categorical variables. Chi-square test was conducted to compare the differences of demographic characteristics between case and control groups. And the mean concentrations of CA125, CA199 and CEA between initial treatment and retreatment, case group and control group were tested by Kruskal-Wallis method of nonparametric test. In our study, the concentrations json of CA125, CA199 and CEA like other references are not normal distribution, and then we selected the non-parametric tests. Furthermore, the Mann-Whitney U test was applied to determine the abnormal rates of three tumor markers between case group and control group. Followed was identified the related serum tumor markers to PTB by logistic regression analysis. Then the ROC curve analysis was conducted to assess the difference between areas under the curve (AUC) which belonged to respective tumor marker and to evaluate the diagnostic sensitivity and specificity at the optimal cut-off. <italic>P</italic>&#x0003c;0.05 was considered to indicate a statistically significant difference. Data management and all analyses were performed using R software program, version 3.0.0 (<ext-link ext-link-type="uri" xlink:href="http://www.R-project.org">http://www.R-project.org</ext-link>).</p></sec></sec><sec sec-type="results"><title>Results</title><sec sec-type="intro"><title>Demographic characteristics</title><p>The case group was completed on 113 cases, including 58 PTB initial treatment patients (37 men, 21 women, age ranged from 16 to 81 yr, average age: 38.16&#x000b1;18.86) and 55 retreatment patients (35 men, 20 women, age ranged from 19 to 91 yr, average age: 52.18&#x000b1;21.22). Matched controls were 452 healthy people (288 men, 164 women, age range 16 to 91 yr old, average age: 45.17&#x000b1;20.97). There were no significant differences of age, sex and smoking between case and control group. In terms of drink and marital status, there were significantly different between two groups (
<xref ref-type="table" rid="T1">Table 1</xref>
).</p><table-wrap id="T1" position="float"><label>Table 1:</label><caption><p>Demographic characteristics of participants</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="bottom" rowspan="1" colspan="1"><bold>Variables</bold></th><th align="center" valign="bottom" rowspan="1" colspan="1"/><th align="center" valign="bottom" rowspan="1" colspan="1"><bold>Case group (n, %)</bold></th><th align="center" valign="bottom" rowspan="1" colspan="1"><bold>Control group (n, %)</bold></th><th align="center" valign="bottom" rowspan="1" colspan="1"><bold><italic>&#x003c7;<sup>2</sup></italic></bold></th><th align="center" valign="bottom" rowspan="1" colspan="1"><bold><italic>P. value</italic></bold></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Sex</td><td align="center" valign="top" rowspan="1" colspan="1">Male</td><td align="center" valign="top" rowspan="1" colspan="1">72 (63.72)</td><td align="center" valign="top" rowspan="1" colspan="1">288 (63.72)</td><td align="center" valign="top" rowspan="1" colspan="1">0.00</td><td align="center" valign="top" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">Female</td><td align="center" valign="top" rowspan="1" colspan="1">41 (36.28)</td><td align="center" valign="top" rowspan="1" colspan="1">164 (36.28)</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Age</td><td align="center" valign="top" rowspan="1" colspan="1">16~44</td><td align="center" valign="top" rowspan="1" colspan="1">58 (51.33)</td><td align="center" valign="top" rowspan="1" colspan="1">232 (51.33)</td><td align="center" valign="top" rowspan="1" colspan="1">0.00</td><td align="center" valign="top" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">45~60</td><td align="center" valign="top" rowspan="1" colspan="1">23 (20.35)</td><td align="center" valign="top" rowspan="1" colspan="1">92 (20.35)</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">&#x0003e;60</td><td align="center" valign="top" rowspan="1" colspan="1">32 (28.32)</td><td align="center" valign="top" rowspan="1" colspan="1">128 (28.32)</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Marital status</td><td align="center" valign="top" rowspan="1" colspan="1">Married</td><td align="center" valign="top" rowspan="1" colspan="1">56 (49.56)</td><td align="center" valign="top" rowspan="1" colspan="1">297 (65.71)</td><td align="center" valign="top" rowspan="1" colspan="1">10.06</td><td align="center" valign="top" rowspan="1" colspan="1">0.002</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">Single</td><td align="center" valign="top" rowspan="1" colspan="1">57 (50.44)</td><td align="center" valign="top" rowspan="1" colspan="1">155 (34.29)</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Smoke</td><td align="center" valign="top" rowspan="1" colspan="1">yes</td><td align="center" valign="top" rowspan="1" colspan="1">0 (0.00)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (0.22)</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">1.000</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Drink</td><td align="center" valign="top" rowspan="1" colspan="1">yes</td><td align="center" valign="top" rowspan="1" colspan="1">89 (78.76)</td><td align="center" valign="top" rowspan="1" colspan="1">139 (30.75)</td><td align="center" valign="top" rowspan="1" colspan="1">86.57</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;0.001</td></tr></tbody></table></table-wrap></sec><sec sec-type="methods"><title>The analysis of concentration levels and abnormal rates of three tumor markers between case and control groups</title><p>The concentration of serum CA125, CA199 and CEA in case group were found significantly higher than those in control group (<italic>P</italic>&#x0003c;0.001) (
<xref ref-type="table" rid="T2">Table 2</xref>
). We also accessed the abnormal rates of three tumor markers between two group, the abnormal rates of CA125 (Case group: 48.67% vs Control group: 0.22%) and CEA (Case group: 7.08% vs Control group: 0.88%) in case group were significantly higher than in control group (<italic>P</italic>&#x0003c;0.001). The abnormal rate of CA199 was no significant different between two groups (
<xref ref-type="table" rid="T3">Table 3</xref>
).</p><table-wrap id="T2" position="float"><label>Table 2:</label><caption><p>The comparison of concentration levels of three tumor markers between case and control group</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" rowspan="1" colspan="1"><bold>Variables</bold></th><th align="center" valign="middle" rowspan="1" colspan="1"><bold>Case group (<italic>n</italic>=113)</bold></th><th align="center" valign="middle" rowspan="1" colspan="1"><bold>Control group (<italic>n</italic>=452)</bold></th><th align="center" valign="middle" rowspan="1" colspan="1"><bold><italic>Z</italic></bold></th><th align="center" valign="middle" rowspan="1" colspan="1"><bold>P. value</bold></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">CA125 (U/ml)</td><td align="center" valign="top" rowspan="1" colspan="1">33.71 (18.70, 68.86)</td><td align="center" valign="top" rowspan="1" colspan="1">5.72 (3.87, 8.14)</td><td align="center" valign="top" rowspan="1" colspan="1">402.64</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CA199 (U/ml)</td><td align="center" valign="top" rowspan="1" colspan="1">9.09 (4.94, 13.55)</td><td align="center" valign="top" rowspan="1" colspan="1">6.06 (4.18, 8.21)</td><td align="center" valign="top" rowspan="1" colspan="1">20.68</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CEA (ng/ml)</td><td align="center" valign="top" rowspan="1" colspan="1">1.89 (1.17, 3.11)</td><td align="center" valign="top" rowspan="1" colspan="1">1.02 (0.68, 1.70)</td><td align="center" valign="top" rowspan="1" colspan="1">52.33</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;0.001</td></tr></tbody></table></table-wrap><table-wrap id="T3" position="float"><label>Table 3:</label><caption><p>The comparison of abnormal rates of three tumor markers between case and control group (n, %)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1"><bold>Variables</bold></th><th align="center" valign="top" rowspan="1" colspan="1"><bold>Case group (<italic>n</italic>=113)</bold></th><th align="center" valign="top" rowspan="1" colspan="1"><bold>Control group (<italic>n</italic>=452)</bold></th><th align="center" valign="top" rowspan="1" colspan="1"><bold><italic>&#x003c7;<sup>2</sup></italic></bold></th><th align="center" valign="top" rowspan="1" colspan="1"><bold><italic>P. value</italic></bold></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">CA125</td><td align="center" valign="top" rowspan="1" colspan="1">55 (48.67)</td><td align="center" valign="top" rowspan="1" colspan="1">1 (0.22)</td><td align="center" valign="top" rowspan="1" colspan="1">237.67</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CEA</td><td align="center" valign="top" rowspan="1" colspan="1">8 (7.08)</td><td align="center" valign="top" rowspan="1" colspan="1">4 (0.88)</td><td align="center" valign="top" rowspan="1" colspan="1">16.69</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CA199</td><td align="center" valign="top" rowspan="1" colspan="1">2 (1.77)</td><td align="center" valign="top" rowspan="1" colspan="1">5 (1.11)</td><td align="center" valign="top" rowspan="1" colspan="1">0.33</td><td align="center" valign="top" rowspan="1" colspan="1">0.568</td></tr></tbody></table></table-wrap></sec><sec sec-type="methods"><title>The analysis of concentration levels of three tumor markers between initial treatment and retreatment group</title><p>To understand whether the retreatment of PTB effect the three tumor markers, we test the levels of serum CA125, CA199 and CEA, there were no significant differences between initial treatment group and retreatment group.</p></sec><sec><title>Evaluation the association of three tumor markers with PTB</title><p>The logistic regression analysis was performed to evaluate the association of three tumor markers with PTB, PTB (case group=1, control group=0) was selected as dependent variable, and CA125, CA199 and CEA were selected as independent variables. The results showed that CA125 was significantly related to PTB (OR = 1.133, <italic>P</italic>&#x0003c;0.001) (
<xref ref-type="table" rid="T4">Table 4</xref>
).</p><table-wrap id="T4" position="float"><label>Table 4:</label><caption><p>The evaluation of association of three tumor markers with PTB by binary logistic regression</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top" rowspan="1" colspan="1"><bold>Factors</bold></th><th align="center" valign="top" rowspan="1" colspan="1"><bold><italic>&#x003b2;</italic></bold></th><th align="center" valign="top" rowspan="1" colspan="1"><bold><italic>SE</italic></bold></th><th align="center" valign="top" rowspan="1" colspan="1"><bold><italic>Wald&#x003c7;<sup>2</sup></italic></bold></th><th align="center" valign="top" rowspan="1" colspan="1"><bold><italic>P</italic></bold></th><th align="center" valign="top" rowspan="1" colspan="1"><bold>OR (95%CI)</bold></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">CA125</td><td align="center" valign="top" rowspan="1" colspan="1">0.115</td><td align="center" valign="top" rowspan="1" colspan="1">0.015</td><td align="center" valign="top" rowspan="1" colspan="1">57.311</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">1.133 (1.101&#x02013;1.166)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CEA</td><td align="center" valign="top" rowspan="1" colspan="1">0.200</td><td align="center" valign="top" rowspan="1" colspan="1">0.126</td><td align="center" valign="top" rowspan="1" colspan="1">2.529</td><td align="center" valign="top" rowspan="1" colspan="1">0.112</td><td align="center" valign="top" rowspan="1" colspan="1">1.222 (0.954&#x02013;1.564)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">CA199</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;0.001</td><td align="center" valign="top" rowspan="1" colspan="1">0.007</td><td align="center" valign="top" rowspan="1" colspan="1">0.033</td><td align="center" valign="top" rowspan="1" colspan="1">0.855</td><td align="center" valign="top" rowspan="1" colspan="1">0.999 (0.985&#x02013;1.013)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Constant</td><td align="center" valign="top" rowspan="1" colspan="1">&#x02212;3.493</td><td align="center" valign="top" rowspan="1" colspan="1">0.281</td><td align="center" valign="top" rowspan="1" colspan="1">154.625</td><td align="center" valign="top" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="center" valign="top" rowspan="1" colspan="1"/></tr></tbody></table></table-wrap></sec><sec sec-type="methods"><title>The analysis of predictive value of three tumor markers by ROC</title><p>The ROC analysis revealed that for CA125, the AUC whose 95% confidence interval ranges from 0.951 to 0.981 was 0.966, and the cut-off value was 10.30, with the sensitivity, specificity 0.956 and 0.850, respectively.</p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>In this study we investigated the diagnostic value of three common clinical serum tumor markers, the CA125, CA199 and CEA in case group were found significantly higher than those in control group, but only CA125 was the positive association factor with PTB, the value of predictive power (AUC) was 0.966, the cut-off, sensitivity and specificity of CA125 were 10.30 U/ml, 0.956 and 0.850, respectively.</p><p>CA125 was identified by molecular cloning (
<xref rid="B18" ref-type="bibr">18</xref>
) and presents in the tracheal, bronchial, bronchiolar, terminal bronchiolar epithelium (
<xref rid="B19" ref-type="bibr">19</xref>
), as a cell surface glycoprotein involved in promoting ovarian cancer cell growth, and it was considered as a specific biological marker for ovarian cancer. However, our study suggested that CA125 was significantly higher PTB patients both in treatment and retreatment, and had higher sensitivity and specificity compare to another Study (
<xref rid="B15" ref-type="bibr">15</xref>
). The possible reason was that severe PTB was associated with more bronchial epithelial cells destruction, which induced the elevated CA125 level in PTB patients (
<xref rid="B16" ref-type="bibr">16</xref>
). A study in Germany explained that it was the inflammatory mesothelial cell proliferation, which induced the secretion of CA125 in patients with TB (
<xref rid="B20" ref-type="bibr">20</xref>
).</p><p>CA199 is another common clinical tumor marker in diagnosis pancreatic cancer (
<xref rid="B21" ref-type="bibr">21</xref>
) and gastric cancer (
<xref rid="B22" ref-type="bibr">22</xref>
). We selected CA199 and tested the diagnosis of predictive value to PTB, since there several case reports showed that CA199 was increased in a PTB patient (
<xref rid="B23" ref-type="bibr">23</xref>
) and in an endobronchial TB patient (
<xref rid="B24" ref-type="bibr">24</xref>
). However, this study found that CA199 had no significant to PTB in multivariables logistic aggression analysis. Canturk Tasci, et al. also reported that there were no statistically significant in CA199 values of PTB group before treatment when compared with that of the healthy control group, and the difference found in CA199 levels before and after treatment in patients with PTB was not statistically significant (<italic>P</italic>&#x0003c;0.08) (
<xref rid="B25" ref-type="bibr">25</xref>
). The reason has been unknown, whatever the results of case report may influenced by some casual factors.</p><p>A report in 1993 demonstrated that elevated serum CEA was found in 16.9% of patients with active pulmonary tuberculosis (
<xref rid="B26" ref-type="bibr">26</xref>
). Especially in female, a report showed that among 6 to 7 female patients with miliary tuberculosis, CEA had elevated (
<xref rid="B27" ref-type="bibr">27</xref>
). These finds were similar to our results, but in our study, CEA in male (1.35) was significantly higher than that in female (0.89), and the AUC of CEA was only 0.710. Thus diagnosing PTB with CEA is not a good method. Differentiating pulmonary tumor from PTB is difficult, in our study there 48.67% PTB case were abnormal according to CA125 normal reference, interestingly, the cut-off in ROC curve of CA125 was 10.30, and it was significantly lower than its normal references of tumor &#x02264; 35U/ml. In other words, it may be a potential bio-marker which can differentiate the pulmonary tumor from PTB.</p><p>The present study has several limitations. Firstly, the patients in case group of this study were recruited only with PTB, thus the results may not be applicable in other type TB. Secondly, both case and control groups, we excluded patients according to imaging findings and clinical experiences instead of tissue biopsy, it was inevitable that the PTB and tumor patients incubation period were enrolled this study. Thirdly, all patients in our study were characterized by sputum smear microscopy and culture including subsequent antigen or molecular confirmation of <italic>Mycobacterium TB</italic> to determine the reference standard, so these results may be not applicable in smear-negative PTB. The mechanism of the association of the serum tumor markers with PTB remains to be further explored.</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>Serum CA125 has good diagnostic performances for PTB, this diagnostic accuracy would surpass that of other available immediate diagnostic options, and could yield a result much more rapidly than cultures.</p></sec><sec><title>Ethical considerations</title><p>Ethical issues (Including plagiarism, informed consent, misconduct, json fabrication and/or falsification, double publication and/or submission, redundancy, etc.) have been completely observed by the authors.</p></sec></body><back><ack><p>The project was supported by the National Innovation Entrepreneurship Training Program for Undergraduate of China (Grant NO. AH20140368010). The authors declare that they have no conflict of interest.</p></ack><ref-list><title>Reference</title><ref id="B1"><label>1.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Maartens</surname><given-names>G</given-names></name><name><surname>Wilkinson</surname><given-names>RJ</given-names></name></person-group>
(<year>2007</year>). 
<article-title>Tuberculosis</article-title>. 
<source>Lancet</source>, 
<volume>370</volume>(
<issue>9604</issue>):
<fpage>2030</fpage>&#x02013;<lpage>43</lpage>.
<pub-id pub-id-type="pmid">17719083</pub-id></mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation publication-type="webpage">
<person-group person-group-type="author"><collab>WHO</collab></person-group>
(<year>2014</year>). 
<article-title>Global Tuberculosis Report 2014</article-title>. 
Available from: 
<ext-link ext-link-type="uri" xlink:href="http://www.who.int/tb/publications/global_report/en/">http://www.who.int/tb/publications/global_report/en/</ext-link>
.
</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>K</given-names></name><name><surname>Fukunaga</surname><given-names>Y</given-names></name><name><surname>Monbayashi</surname><given-names>J</given-names></name><name><surname>Arima</surname><given-names>K</given-names></name><name><surname>Shimouchi</surname><given-names>A</given-names></name></person-group>
(<year>2009</year>). 
<article-title>Investigation on&#x0201c; patient's delay&#x0201d; in TB detection</article-title>. 
<source>Kekkaku</source>, 
<volume>84</volume> (
<issue>7</issue>):
<fpage>523</fpage>&#x02013;<lpage>9</lpage>.
<pub-id pub-id-type="pmid">19670799</pub-id></mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Srikanth</surname><given-names>P</given-names></name><name><surname>Kamesh</surname><given-names>S</given-names></name><name><surname>Daley</surname><given-names>P</given-names></name></person-group>
(<year>2009</year>). 
<article-title>Bleach optimization of sputum smear microscopy for pulmonary tuberculosis</article-title>. 
<source>Indian J Tuberc</source>, 
<volume>56</volume> (
<issue>4</issue>):
<fpage>174</fpage>&#x02013;<lpage>84</lpage>.
<pub-id pub-id-type="pmid">20469728</pub-id></mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ekinci</surname><given-names>GH</given-names></name><name><surname>Karakaya</surname><given-names>E</given-names></name><name><surname>Ongel</surname><given-names>EA</given-names></name><name><surname>Haciomeroglu</surname><given-names>O</given-names></name><name><surname>Yilmaz</surname><given-names>A</given-names></name></person-group>
(<year>2014</year>). 
<article-title>Patient and Doctor Delays in Smear-Negative and Smear-Positive Pulmonary Tuberculosis Patients Attending a Referral Hospital in Istanbul, Turkey</article-title>. 
<source>ScientificWorldJournal</source>, 
<fpage>158186</fpage>.
<pub-id pub-id-type="pmid">25379517</pub-id></mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Burgess</surname><given-names>LJ</given-names></name><name><surname>Swanepoel</surname><given-names>CG</given-names></name><name><surname>Taljaard</surname><given-names>JJ</given-names></name></person-group>
(<year>2001</year>). 
<article-title>The use of adenosine deaminase as a diagnostic tool for peritoneal tuberculosis</article-title>. 
<source>Tuberculosis (Edinb)</source>, 
<volume>81</volume> (
<issue>3</issue>):
<fpage>243</fpage>&#x02013;<lpage>8</lpage>.
<pub-id pub-id-type="pmid">11466036</pub-id></mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Afrasiabian</surname><given-names>S</given-names></name><name><surname>Mohsenpour</surname><given-names>B</given-names></name><name><surname>Bagheri</surname><given-names>KH</given-names></name><name><surname>Sigari</surname><given-names>N</given-names></name><name><surname>Aftabi</surname><given-names>K</given-names></name></person-group>
(<year>2013</year>). 
<article-title>Diagnostic value of serum adenosine deaminase level in pulmonary tuberculosis</article-title>. 
<source>J Res Med Sci</source>, 
<volume>18</volume> (
<issue>3</issue>):
<fpage>252</fpage>&#x02013;<lpage>4</lpage>.
<pub-id pub-id-type="pmid">23930125</pub-id></mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Haldar</surname><given-names>S</given-names></name><name><surname>Sankhyan</surname><given-names>N</given-names></name><name><surname>Sharma</surname><given-names>N</given-names></name><name><surname>Bansal</surname><given-names>A</given-names></name><name><surname>Jain</surname><given-names>V</given-names></name><name><surname>Gupta</surname><given-names>V</given-names></name><etal/></person-group>
(<year>2012</year>). 
<article-title>Detection of Mycobacterium tuberculosis GlcB or HspX Antigens or devR DNA impacts the rapid diagnosis of tuberculous meningitis in children</article-title>. 
<source>PloS One</source>, 
<volume>7</volume> (
<issue>9</issue>):
<fpage>e44630</fpage>.
<pub-id pub-id-type="pmid">22984534</pub-id></mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wallis</surname><given-names>RS</given-names></name><name><surname>Pai</surname><given-names>M</given-names></name><name><surname>Menzies</surname><given-names>D</given-names></name><name><surname>Doherty</surname><given-names>TM</given-names></name><name><surname>Walzl</surname><given-names>G</given-names></name><name><surname>Perkins</surname><given-names>MD</given-names></name><name><surname>Zumla</surname><given-names>A</given-names></name></person-group>
(<year>2010</year>). 
<article-title>Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice</article-title>. 
<source>Lancet</source>, 
<volume>375</volume> (
<issue>9729</issue>):
<fpage>1920</fpage>&#x02013;<lpage>37</lpage>.
<pub-id pub-id-type="pmid">20488517</pub-id></mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Tian</surname><given-names>YP</given-names></name></person-group>
(<year>2014</year>). 
<article-title>Clinical value of serum tumor markers CA199, CA125 and CA72-4 in the diagnosis of pancreatic carcinoma</article-title>. 
<source>Mol Clin Oncol</source>, 
<volume>2</volume> (
<issue>2</issue>):
<fpage>265</fpage>&#x02013;<lpage>8</lpage>.
<pub-id pub-id-type="pmid">24649344</pub-id></mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>He</surname><given-names>CZ</given-names></name><name><surname>Zhang</surname><given-names>KH</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>XH</given-names></name><name><surname>Hong</surname><given-names>Y</given-names></name><name><surname>Lv</surname><given-names>NH</given-names></name></person-group>
(<year>2013</year>). 
<article-title>Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer</article-title>. 
<source>BMC Gastroenterol</source>, 
<volume>13</volume> (
<issue>1</issue>):
<fpage>87</fpage>.
<pub-id pub-id-type="pmid">23672279</pub-id></mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fernandez</surname><given-names>J</given-names></name><name><surname>De Quiros</surname><given-names>B</given-names></name><name><surname>Telenti</surname><given-names>M</given-names></name><name><surname>Suarez Leiva</surname><given-names>P</given-names></name><name><surname>Fernandez Llana</surname><given-names>B</given-names></name><name><surname>Allende</surname><given-names>MT</given-names></name><name><surname>Ruibal Morell</surname><given-names>A</given-names></name></person-group>
(<year>1995</year>). 
<article-title>CA125 Serum levels in tubercolosis patients</article-title>. 
<source>Int J Biol Markers</source>, 
<volume>10</volume> (
<issue>3</issue>):
<fpage>180</fpage>&#x02013;<lpage>1</lpage>.
<pub-id pub-id-type="pmid">8551062</pub-id></mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sulaiman</surname><given-names>S</given-names></name><name><surname>Tan</surname><given-names>KH</given-names></name></person-group>
(<year>2009</year>). 
<article-title>Markedly-elevated serum CA125 in a woman with pulmonary tuberculosis</article-title>. 
<source>Singapore Med J</source>, 
<volume>50</volume> (
<issue>1</issue>):
<fpage>e39</fpage>&#x02013;<lpage>40</lpage>.
<pub-id pub-id-type="pmid">19224069</pub-id></mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sekiya</surname><given-names>K</given-names></name><name><surname>Sakai</surname><given-names>T</given-names></name><name><surname>Homma</surname><given-names>S</given-names></name><name><surname>Tojima</surname><given-names>H</given-names></name></person-group>
(<year>2007</year>). 
<article-title>Pulmonary tuberculosis accompanied by a transient increase in serum carcinoembryonic antigen level with tuberculous empyema drainage</article-title>. 
<source>Intern Med</source>, 
<volume>46</volume> (
<issue>21</issue>):
<fpage>1795</fpage>&#x02013;<lpage>8</lpage>.
<pub-id pub-id-type="pmid">17978537</pub-id></mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Racil</surname><given-names>H</given-names></name><name><surname>Saad</surname><given-names>S</given-names></name><name><surname>Rouhou</surname><given-names>SC</given-names></name><name><surname>Chaouch</surname><given-names>N</given-names></name><name><surname>Zarrouk</surname><given-names>M</given-names></name><name><surname>Yaalaoui</surname><given-names>S</given-names></name><name><surname>Chabbou</surname><given-names>A</given-names></name></person-group>
(<year>2009</year>). 
<article-title>The value of tumor markers in pulmonary tuberculosis</article-title>. 
<source>Tunis Med</source>, 
<volume>87</volume> (
<issue>5</issue>):
<fpage>330</fpage>&#x02013;<lpage>3</lpage>.
<pub-id pub-id-type="pmid">19927764</pub-id></mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kim</surname><given-names>ES</given-names></name><name><surname>Park</surname><given-names>KU</given-names></name><name><surname>Song</surname><given-names>J</given-names></name><name><surname>Lim</surname><given-names>HJ</given-names></name><name><surname>Cho</surname><given-names>YJ</given-names></name><name><surname>Yoon</surname><given-names>H</given-names></name><etal/></person-group>
(<year>2013</year>). 
<article-title>The clinical significance of CA-125 in pulmonary tuberculosis</article-title>. 
<source>Tuberculosis (Edinb)</source>, 
<volume>93</volume> (
<issue>2</issue>):
<fpage>222</fpage>&#x02013;<lpage>6</lpage>.
<pub-id pub-id-type="pmid">23414674</pub-id></mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation publication-type="webpage">
<person-group person-group-type="author"><collab>WHO</collab></person-group>
(<year>2013</year>). 
<article-title>Definitions and reporting framework for tuberculosis&#x02013;2013 revision</article-title>. 
Available from: <ext-link ext-link-type="uri" xlink:href="http://apps.who.int/iris/bitstream/10665/79199/1/9789241505345_eng.pdf">http://apps.who.int/iris/bitstream/10665/79199/1/9789241505345_eng.pdf</ext-link>
</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yin</surname><given-names>BW</given-names></name><name><surname>Lloyd</surname><given-names>KO</given-names></name></person-group>
(<year>2001</year>). 
<article-title>Molecular Cloning of the CA125 Ovarian Cancer Antigen Identificationasa New Mucin, MUC16</article-title>. 
<source>J Biol Chem</source>, 
<volume>276</volume> (
<issue>29</issue>):
<fpage>27371</fpage>&#x02013;<lpage>5</lpage>.
<pub-id pub-id-type="pmid">11369781</pub-id></mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nouwen</surname><given-names>EJ</given-names></name><name><surname>Pollet</surname><given-names>DE</given-names></name><name><surname>Eerdekens</surname><given-names>MW</given-names></name><name><surname>Hendrix</surname><given-names>PG</given-names></name><name><surname>Briers</surname><given-names>TW</given-names></name><name><surname>De Broe</surname><given-names>ME</given-names></name></person-group>
(<year>1986</year>). 
<article-title>Immunohistochemical localization of placental alkaline phosphatase, carcinoembryonic antigen, and cancer antigen 125 in normal and neoplastic human lung</article-title>. 
<source>Cancer Res</source>, 
<volume>46</volume> (
<issue>2</issue>):
<fpage>866</fpage>&#x02013;<lpage>76</lpage>.
<pub-id pub-id-type="pmid">3510076</pub-id></mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ronay</surname><given-names>G</given-names></name><name><surname>J ger</surname><given-names>W</given-names></name><name><surname>Tulusan</surname><given-names>A</given-names></name></person-group>
(<year>1989</year>). 
<article-title>Immunohistochemical and serologic detection of Ca-125 in patients with peritoneal tuberculosis and ascites</article-title>. 
<source>Geburtshilfe Frauenheilkd</source>, 
<volume>49</volume> (
<issue>1</issue>):
<fpage>61</fpage>&#x02013;<lpage>3</lpage>.
<pub-id pub-id-type="pmid">2917708</pub-id></mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ni</surname><given-names>XG</given-names></name><name><surname>Bai</surname><given-names>XF</given-names></name><name><surname>Mao</surname><given-names>YL</given-names></name><name><surname>Shao</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Shan</surname><given-names>Y</given-names></name></person-group>
(<year>2005</year>). 
<article-title>The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer</article-title>. 
<source>Eur J Surg Oncol</source>, 
<volume>31</volume> (
<issue>2</issue>):
<fpage>164</fpage>&#x02013;<lpage>9</lpage>.
<pub-id pub-id-type="pmid">15698733</pub-id></mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ferrone</surname><given-names>CR</given-names></name><name><surname>Finkelstein</surname><given-names>DM</given-names></name><name><surname>Thayer</surname><given-names>SP</given-names></name><name><surname>Muzikansky</surname><given-names>A</given-names></name><name><surname>Fernandez-del Castillo</surname><given-names>C</given-names></name><name><surname>Warshaw</surname><given-names>AL</given-names></name></person-group>
(<year>2006</year>). 
<article-title>Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma</article-title>. 
<source>J Clin Oncol</source>, 
<volume>24</volume> (
<issue>18</issue>):
<fpage>2897</fpage>&#x02013;<lpage>902</lpage>.
<pub-id pub-id-type="pmid">16782929</pub-id></mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ishiura</surname><given-names>Y</given-names></name><name><surname>Fujimura</surname><given-names>M</given-names></name><name><surname>Minami</surname><given-names>S</given-names></name><name><surname>Ueda</surname><given-names>A</given-names></name><name><surname>Iwata</surname><given-names>M</given-names></name><name><surname>Watanabe</surname><given-names>K</given-names></name><etal/></person-group>
(<year>1996</year>). 
<article-title>Increased CA19-9 level in serum and bronchoalveolar lavage fluid from a patient with pulmonary tuberculosis</article-title>. 
<source>Nihon Kyobu Shikkan Gakkai Zasshi</source>, 
<volume>34</volume> (
<issue>4</issue>):
<fpage>477</fpage>&#x02013;<lpage>81</lpage>.
<pub-id pub-id-type="pmid">8691672</pub-id></mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Komiya</surname><given-names>T</given-names></name><name><surname>Matsushima</surname><given-names>T</given-names></name><name><surname>Kimura</surname><given-names>M</given-names></name><name><surname>Adachi</surname><given-names>M</given-names></name></person-group>
(<year>1994</year>). 
<article-title>A case of endobronchial tuberculosis with high serum CA19-9 and SLX level</article-title>. 
<source>Kekkaku</source>, 
<volume>69</volume> (
<issue>10</issue>):
<fpage>615</fpage>&#x02013;<lpage>9</lpage>.
<pub-id pub-id-type="pmid">7799572</pub-id></mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tasci</surname><given-names>C</given-names></name><name><surname>Ozkaya</surname><given-names>S</given-names></name><name><surname>Ozkara</surname><given-names>B</given-names></name><name><surname>Tozkoparan</surname><given-names>E</given-names></name><name><surname>Ozkan</surname><given-names>M</given-names></name><name><surname>Karadurmus</surname><given-names>N</given-names></name><etal/></person-group>
(<year>2012</year>). 
<article-title>The utility of tumor markers CA 125, CA 15-3, and CA 19-9 in assessing the response to therapy in pulmonary and pleural tuberculosis</article-title>. 
<source>Onco Targets Ther</source>, 
<volume>5</volume>:
<fpage>385</fpage>&#x02013;<lpage>90</lpage>.
<pub-id pub-id-type="pmid">23209372</pub-id></mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ichiki</surname><given-names>H</given-names></name><name><surname>Shishido</surname><given-names>M</given-names></name><name><surname>Nishitani</surname><given-names>K</given-names></name><name><surname>Takatsugi</surname><given-names>K</given-names></name><name><surname>Nishiyama</surname><given-names>S</given-names></name><name><surname>Yano</surname><given-names>M</given-names></name><name><surname>Watanabe</surname><given-names>K</given-names></name></person-group>
(<year>1993</year>). 
<article-title>Evaluation of CEA, SLX and CA125 in active pulmonary tuberculosis</article-title>. 
<source>Nihon Kyobu Shikkan Gakkai Zasshi</source>, 
<volume>31</volume> (
<issue>12</issue>):
<fpage>1522</fpage>&#x02013;<lpage>7</lpage>.
<pub-id pub-id-type="pmid">7907156</pub-id></mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hamamoto</surname><given-names>Y</given-names></name><name><surname>Koyama</surname><given-names>H</given-names></name><name><surname>Hashihira</surname><given-names>M</given-names></name><name><surname>Taniguchi</surname><given-names>T</given-names></name><name><surname>Hashimoto</surname><given-names>K</given-names></name><name><surname>Osako</surname><given-names>T</given-names></name></person-group>
(<year>1994</year>). 
<article-title>Clinical studies on nine cases with miliary tuberculosis: serum level of tumor markers and bronchoscopy in differential diagnosis</article-title>. 
<source>Kekkaku</source>, 
<volume>69</volume> (
<issue>11</issue>):
<fpage>681</fpage>&#x02013;<lpage>7</lpage>.
<pub-id pub-id-type="pmid">7837721</pub-id></mixed-citation></ref></ref-list></back></article>